<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04143399</url>
  </required_header>
  <id_info>
    <org_study_id>62513</org_study_id>
    <nct_id>NCT04143399</nct_id>
  </id_info>
  <brief_title>HoLEP vs BPRP of a Large Volume BPH: a Randomised Controlled Trial</brief_title>
  <official_title>Holmium Laser Enucleation vs Bipolar Resection of a Large Volume BPH: a Randomised Controlled Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cairo University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cairo University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To compare bipolar resection versus holmium laser enucleation for management of large BPH.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      To compare safety and efficacy of bipolar resection (BPRP) versus holmium laser enucleation
      (HoLEP) for management of large BPH (&gt; 75 gm).
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">February 14, 2016</start_date>
  <completion_date type="Actual">June 10, 2019</completion_date>
  <primary_completion_date type="Actual">May 1, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>hemoglobin drop postoperatively (gm/dL)</measure>
    <time_frame>Immediate postoperatively</time_frame>
    <description>difference in hemoglobin concentration postoperatively vs preoperatively</description>
  </primary_outcome>
  <primary_outcome>
    <measure>operative duration in minutes</measure>
    <time_frame>during surgery</time_frame>
    <description>operative duration</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Hospital stay in days</measure>
    <time_frame>immediately after surgery</time_frame>
    <description>Hospital stay</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>complications (%)</measure>
    <time_frame>Two years</time_frame>
    <description>intraoperative and postoperative complications including blood transfusion, capsular perforation, irritative symptoms, SUI, urethral stricture, bladder neck contracture, urinary retention.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>urine flow</measure>
    <time_frame>Two years</time_frame>
    <description>Qmax (ml/s),</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>post-voiding residual urine</measure>
    <time_frame>Two years</time_frame>
    <description>postvoiding residual urine (ml)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>International prostate symptom score (IPSS)</measure>
    <time_frame>Two years</time_frame>
    <description>an international commonly used score ranging from 0 - 35 (the worst is 35) evaluating voiding and storage urinary symptoms using 7 questions each one is scored from 0 to 5 according to severity of symptom</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of life (QoL)</measure>
    <time_frame>Two years</time_frame>
    <description>section of International prostate symptom score (IPSS) one question scored from 0 up to 6 (6 is worst)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Catheter duration</measure>
    <time_frame>immediate postoperatively</time_frame>
    <description>Catheter duration in hours</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">145</enrollment>
  <condition>BPH With Urinary Obstruction</condition>
  <condition>Male</condition>
  <arm_group>
    <arm_group_label>holmium laser enucleation of the prostate</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>holmium laser enucleation of the prostate (HoLEP)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>bipolar resection of the prostate</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>bipolar resection of the prostate (BPEP)</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>holmium laser enucleation of the prostate</intervention_name>
    <description>cystoscopic transurethral enucleation of the prostate using Holmium laser (Versa pulse 100W; Lumenis; Germany)</description>
    <arm_group_label>holmium laser enucleation of the prostate</arm_group_label>
    <other_name>HoLEP</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Bipolar resection of the prostate</intervention_name>
    <description>cystoscopic transurethral resection of the prostate using bipolar energy</description>
    <arm_group_label>bipolar resection of the prostate</arm_group_label>
    <other_name>BPRP</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients suffering from LUTS secondary to infravesical obstruction from BPH

          -  failed medical treatment

          -  International Prostate Symptom Score (IPSS) &gt; 13

          -  a peak urinary flow rate (Qmax) &lt; 15 ml/sec

          -  a prostate size â‰¥ 75 gm

        Exclusion Criteria:

          -  presence of a urethral stricture

          -  neurological disorder

          -  bladder cancer

          -  prostate cancer

          -  previous history of bladder neck surgery or TURP
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>45 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>enmar I Habib</last_name>
    <role>Study Director</role>
    <affiliation>Cairo University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Cairo University Hospitals</name>
      <address>
        <city>Cairo</city>
        <zip>12222</zip>
        <country>Egypt</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>October 2019</verification_date>
  <study_first_submitted>October 26, 2019</study_first_submitted>
  <study_first_submitted_qc>October 26, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">October 29, 2019</study_first_posted>
  <last_update_submitted>October 26, 2019</last_update_submitted>
  <last_update_submitted_qc>October 26, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">October 29, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Cairo University</investigator_affiliation>
    <investigator_full_name>Mohammed Said ElSheemy</investigator_full_name>
    <investigator_title>Professor of Urology</investigator_title>
  </responsible_party>
  <keyword>BPH</keyword>
  <keyword>enucleation</keyword>
  <keyword>Large Prostate</keyword>
  <keyword>LUTS</keyword>
  <keyword>IPSS</keyword>
  <keyword>quality of life</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

